Cargando…

Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades

Candida auris is an emerging multiresistant yeast against which amphotericin B (AMB) is still the first therapeutic choice in certain clinical situations (i.e., meningitis, endophthalmitis, and urinary tract infections). As data about the in vitro killing activity of AMB against C. auris clades are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papp, Zoltán, Borman, Andrew M., Forgács, Lajos, Kovács, Renátó, Tóth, Zoltán, Chun-Ju, Chiu, Kardos, Gábor, Juhász, Béla, Szilvássy, Judit, Majoros, László
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398933/ https://www.ncbi.nlm.nih.gov/pubmed/34451454 http://dx.doi.org/10.3390/pathogens10080990

Ejemplares similares

In Vivo Efficacy of Amphotericin B against Four Candida auris Clades
por: Forgács, Lajos, et al.
Publicado: (2022)

In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades
por: Adnan, Awid, et al.
Publicado: (2023)

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum
por: Kovács, Renátó, et al.
Publicado: (2021)

Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model
por: Forgács, Lajos, et al.
Publicado: (2020)

In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris
por: Nagy, Fruzsina, et al.
Publicado: (2020)

Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol
por: Balla, Noémi, et al.
Publicado: (2023)

The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms
por: Kovács, Renátó, et al.
Publicado: (2021)

In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae
por: Tóth, Zoltán, et al.
Publicado: (2019)

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species
por: Tóth, Zoltán, et al.
Publicado: (2020)

Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure
por: Jakab, Ágnes, et al.
Publicado: (2021)

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
por: Prépost, Eszter, et al.
Publicado: (2019)

The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms
por: Tóth, Zoltán, et al.
Publicado: (2022)

Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms
por: Balla, Noémi, et al.
Publicado: (2022)

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against Candida auris
por: Caballero, Unai, et al.
Publicado: (2021)

Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four Candida auris Clades: In Vitro and In Vivo Assays
por: Marena, Gabriel Davi, et al.
Publicado: (2023)

Potential Fifth Clade of Candida auris, Iran, 2018
por: Chow, Nancy A., et al.
Publicado: (2019)

Induction of amphotericin B resistance in susceptible Candida auris by extracellular vesicles
por: Chan, Walton, et al.
Publicado: (2022)

Candida auris in the UK: Introduction, dissemination, and control
por: Borman, Andrew M., et al.
Publicado: (2020)

Diagnostic Allele-Specific PCR for the Identification of Candida auris Clades
por: Carolus, Hans, et al.
Publicado: (2021)

Raman Metabolomics of Candida auris Clades: Profiling and Barcode Identification
por: Pezzotti, Giuseppe, et al.
Publicado: (2022)

Confirmation of fifth Candida auris clade by whole genome sequencing
por: Spruijtenburg, Bram, et al.
Publicado: (2022)

In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris
por: Caballero, Unai, et al.
Publicado: (2021)

Genomic Characterizations of Clade III Lineage of Candida auris, California, USA
por: Price, Travis K., et al.
Publicado: (2021)

Clade-specific chromosomal rearrangements and loss of subtelomeric adhesins in Candida auris
por: Muñoz, José F, et al.
Publicado: (2021)

An Autochthonous Susceptible Candida auris Clade I Otomycosis Case in Iran
por: Ahmadi, Bahram, et al.
Publicado: (2023)

Long Term Osmotic Mini Pump Treatment with Alpha-MSH Improves Myocardial Function in Zucker Diabetic Fatty Rats
por: Szokol, Miklos, et al.
Publicado: (2017)

Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease
por: Priksz, Daniel, et al.
Publicado: (2018)

The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy
por: Bombicz, Mariann, et al.
Publicado: (2019)

Killing of Candida auris by UV‐C: Importance of exposure time and distance
por: de Groot, Theun, et al.
Publicado: (2019)

Clade II Candida auris possess genomic structural variations related to an ancestral strain
por: Sekizuka, Tsuyoshi, et al.
Publicado: (2019)

SCA Medium: A New Culture Medium for the Isolation of All Candida auris Clades
por: Ibrahim, Ahmad, et al.
Publicado: (2021)

High-Throughput Profiling of Candida auris Isolates Reveals Clade-Specific Metabolic Differences
por: Brandt, Philipp, et al.
Publicado: (2023)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates
por: de-la-Fuente, Iñigo, et al.
Publicado: (2023)

Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species
por: Borman, Andrew M., et al.
Publicado: (2016)

An Advanced in Silico Modelling of the Interaction between FSCPX, an Irreversible A(1) Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium
por: Szabo, Adrienn Monika, et al.
Publicado: (2019)

Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life
por: Zsuga, Judit, et al.
Publicado: (2017)

The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications
por: Ráduly, Arnold Péter, et al.
Publicado: (2022)

Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment
por: Wachal, Zita, et al.
Publicado: (2021)

Corrigendum: Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment
por: Wachal, Zita, et al.
Publicado: (2022)

Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
por: Sherry, Leighann, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1jam3kc6m3hnmgeiku9ulaqt99